InvestorsObserver
×
News Home

Citius Pharmaceuticals Inc (CTXR) has risen 6.50% Thursday In Premarket Trading

Thursday, January 26, 2023 06:56 AM | InvestorsObserver Analysts

Mentioned in this article

Citius Pharmaceuticals Inc (CTXR) has risen 6.50% Thursday In Premarket Trading

Citius Pharmaceuticals Inc (CTXR) is up Thursday morning, with the stock rising 6.50% in pre-market trading to 1.31. CTXR's short-term technical score of 81 indicates that the stock has traded more bullishly over the last month than 81% of stocks on the market. In the Biotechnology industry, which ranks 111 out of 146 industries, CTXR ranks higher than 83% of stocks. Citius Pharmaceuticals Inc has risen 46.43% over the past month, closing at $0.85 on December 29. During this period of time, the stock fell as low as $0.78 and as high as $1.48. CTXR has an average analyst recommendation of Strong Buy. The company has an average price target of $8.00.

Overall Score - 65
CTXR has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on CTXR!
Citius Pharmaceuticals Inc has a Long-Term Technical rank of 38. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 62% of the market scoring higher. In the Biotechnology industry which is number 125 by this metric, CTXR ranks better than 125% of stocks.

Important Dates for Investors in CTXR:

-Citius Pharmaceuticals Inc is set to release earnings on 2/9/2023. Over the last 12 months, the company has reported EPS of $-0.22. -We do not have a set dividend date for Citius Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Citius Pharmaceuticals Inc (CTXR)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App